PMA device
Heartmate Xve Lvas
Thoratec Corp · Ventricular (Assist) Bypass (DSQ, Class III) · First FDA decision Oct 31, 2003, newest Dec 21, 2011Heart failure
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
1
Naming "Heartmate Xve Lvas"
MAUDE reports
0
Brand "Heartmate Xve Lvas", since 2015
PubMed studies
3
Mentioning "Heartmate Xve Lvas"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Heartmate Xve Lvas
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- HEARTMATE XVE LVASPMA supplement
P920014-S031 · Decided Dec 21, 2011 · 359 days after receipt · Normal 180 Day Track No User Fee
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
- THORATEC HEARTMATE XVE LVASPMA supplement
P920014-S029 · Decided Mar 13, 2009 · 239 days after receipt · Normal 180 Day Track
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
- THORATEC HEARTMATE XVE LVASPMA supplement
P920014-S021 · Decided Oct 31, 2003 · 191 days after receipt · Normal 180 Day Track
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Heartmate Xve Lvas", any status and sponsor, newest update first.
- Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination TherapyPivotal-lookingCompleted
Abbott Medical DevicesPublic (ABT)
NCT00121485 · 200 participants · Start Feb 2005 · Primary completion Jun 2009
Device: Left Ventricular Assist System (LVAS) · For: Heart Failure, Congestive; Ventricular Dysfunction; Cardiomyopathies
Sites: Birmingham, Alabama; Phoenix, Arizona; San Diego, California · 47 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Heartmate Xve Lvas", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DSQ
146,258 reports: 55,625 malfunction, 69,145 injury, 21,450 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0422-2010 · Started Oct 14, 2009 · Posted by FDA Nov 24, 2009
Reason given: Patient reports alerted Thoratec that during the process of disconnecting power leads from the battery clips, the threaded connector of the battery clip housing was observed to be loose, and in some cases dislodged from the battery clip housing. The problem affects HeartMate 12V SLA Battery Clips including those used...
Cause as FDA categorized it: Other · Device type: Ventricular (Assist) Bypass (DSQ)
Z-0015-2007 · Started Jan 26, 2004 · Posted by FDA Oct 4, 2006
Reason given: During use an unexpected flaking of the inner surface coating (blood contact) that has the potential for risk of embolism.
Cause as FDA categorized it: Other · Device type: Ventricular (Assist) Bypass (DSQ)
Published research
The most relevant PubMed records for "Heartmate Xve Lvas"[tiab]. The summary above synthesizes these.
- HeartMate VE LVAS design enhancements and its impact on device reliability.
Dowling RD, Park SJ, Pagani FD, et al. · Eur J Cardiothorac Surg · 2004Evaluation Study
- State of the art: implantable ventricular assist devices.
Lahpor JR · Curr Opin Organ Transplant · 2009Review
- First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report.
Frazier OH, Delgado RM, Kar B, et al. · Tex Heart Inst J · 2004Case Reports
Other devices of this type
Also filed under product code DSQ.
- HeartWare® Ventricular Assist SystemMedtronic · PMA 2026
- HeartMate 3 Left Ventricular Assist SystemAbbott Medical · PMA 2026
- HeartWare HVAD SystemMedtronic · PMA 2026
- Thoratec Ventricular Assist Device (Vad)Thoratec Laboratories Corp. · PMA 2013
- HeartMate II Left Ventricular Assist SystemAbbott Medical · PMA 2026
- CentriMag Circulatory Support SystemAbbott · PMA 2025
- EXCOR Pediatric Ventricular Assist DeviceBerlin Heart, Inc. · PMA 2026
- Thoratec Heartmate II Left Ventricular Assist SystemAbbott Medical · PMA 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.